OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multi-omics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney Disease
DengFeng Li, Fang‐Chi Hsu, Nicholette D. Palmer, et al.
Diabetes (2024) Vol. 73, Iss. 7, pp. 1188-1195
Open Access | Times Cited: 9
DengFeng Li, Fang‐Chi Hsu, Nicholette D. Palmer, et al.
Diabetes (2024) Vol. 73, Iss. 7, pp. 1188-1195
Open Access | Times Cited: 9
Showing 9 citing articles:
The threshold effect of triglyceride glucose index on diabetic kidney disease risk in patients with type 2 diabetes: unveiling a non-linear association
Huabin Wang, Guangming Chen, Dongmei Sun, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Huabin Wang, Guangming Chen, Dongmei Sun, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy
Ruijing Zhang, Runze Chang, Heng Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Ruijing Zhang, Runze Chang, Heng Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Serum metabolic profiling of patients with diabetic kidney disease based on gas chromatography-mass spectrometry
Xueyan Bian, Changjun Wang, Majie Wang, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Xueyan Bian, Changjun Wang, Majie Wang, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Multi-Omics Integration in Nephrology: Advances, Challenges, and Future Directions
Afaf Saliba, Yuheng Du, Tianqing Feng, et al.
Seminars in Nephrology (2025), pp. 151584-151584
Open Access
Afaf Saliba, Yuheng Du, Tianqing Feng, et al.
Seminars in Nephrology (2025), pp. 151584-151584
Open Access
Genetic studies on metabolic disorder associated kidney diseases
Minako Imamura, Takashi Kadowaki, Shiro Maeda
Kidney International (2025)
Closed Access
Minako Imamura, Takashi Kadowaki, Shiro Maeda
Kidney International (2025)
Closed Access
Aldo-keto reductase (AKR) superfamily website and database: An update
Andrea Andress Huacachino, Jaehyun Joo, Nisha Narayanan, et al.
Chemico-Biological Interactions (2024) Vol. 398, pp. 111111-111111
Closed Access | Times Cited: 3
Andrea Andress Huacachino, Jaehyun Joo, Nisha Narayanan, et al.
Chemico-Biological Interactions (2024) Vol. 398, pp. 111111-111111
Closed Access | Times Cited: 3
Integrated multiomic analyses: An approach to improve understanding of diabetic kidney disease
Claire Hill, Amy Jayne McKnight, Laura J. Smyth
Diabetic Medicine (2024)
Open Access | Times Cited: 1
Claire Hill, Amy Jayne McKnight, Laura J. Smyth
Diabetic Medicine (2024)
Open Access | Times Cited: 1
All three in one: it’s a cohort, proteomics, and Mendelian randomization biomarker study
Jun Wada
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access
Jun Wada
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access
AKR1A1 and Kidney Disease: Promise and Perils of the Multiverse
Matthew D. Breyer
Diabetes (2024) Vol. 73, Iss. 7, pp. 1046-1047
Open Access
Matthew D. Breyer
Diabetes (2024) Vol. 73, Iss. 7, pp. 1046-1047
Open Access
